All Access Pass - 1 FREE Month!
Institutional email required, no credit card necessary.

Cerebral Venous Sinus Thrombosis

Epidemiology
  • Annual incidence ~ 1 per 100,000
  • Female to male ratio of 3:1.
    • Secondary to pregnancy (and the early postpartum period) and the prothrombotic effects of oral contraceptives and hormone replacement therapy.
Pathophysiology
  • Cerebral vein and/or dural sinus thrombosis obstructs drainage of blood and CSF, which increases venous and capillary pressures and intracranial pressure.
    • These increased pressures lead to reduced CSF reabsorption and blood-brain barrier breakdown with resultant venous infarcts, hemorrhage and cerebral edema (severe vasogenic edema, early, and cytotoxic edema with infarction).
Risk Factors and Causes
  • Genetic Thrombophilias
    • Prothrombin G20210A
    • Factor V Leiden
    • Antithrombin deficiency
    • Protein C deficiency
    • Protein S deficiency
    • Hyperhomocysteinemia (MTHFR gene mutation for methylenetetrahydrofolate reductase)
  • Acquired Thrombophilias
    • Pregnancy and the early postpartum period
    • Oral contraceptives and hormone replacement therapy
    • Malignancy
    • Infection
  • Traumatic causes (uncommon)
    • Direct head trauma
    • Lumbar puncture
Clinical Presentation
Highly varied onset: acute, subacute, or chronic
  • Headache
    • Commonly the presenting symptom
    • Can be gradual or sudden in onset
    • Associated intracranial hypertension
  • Intracranial hypertension
    • Headache that worsens with Valsalva and supine position
    • Visual obscuration
    • Physical exam findings of papilledema and reduction in blind spots
  • Cognitive dysfunction
    • Personality changes
    • Delirium
    • Isolated abnormalities (eg, language deficits)
  • Focal motor/sensory/visual deficits
  • Seizures
  • Encephalopathy
Imaging Characteristics
Head CT
  • Intracranial hemorrhage and edema
  • Dense clot sign (aka cord sign)
    • Thrombosed cortical vein
  • Dense triangle sign
    • Posterior superior sagittal sinus contains a triangular or round shape hyperdensity.
Contrast enhancement
  • Empty delta sign
    • Posterior superior sagittal sinus contains a central region that lacks contrast enhancement.
MRI
  • Focal areas venous infarction
    • Absence of flow void
    • Infarcts may include intracerebral hemorrhage
    • Atypical infarction (crosses typical arterial boundaries)
    • Superior sagittal sinus thrombosis produces small (< 2 cm) juxtacortical hemorrhages
  • Diffuse vasogenic edema
MRI Venography or CT Venography
  • Dural thrombus
  • Cortical vein thrombosis
Laboratory Studies
  • Routine studies
    • CBC (looking for infection or thrombocytosis)
    • BMP
    • PT/INR, PTT (looking for coagulopathy)
  • Hypercoagulopathy evaluation
    • Evaluation as clinically appropriate
  • D-dimer (positive test may support the diagnosis)
  • CSF Studies
    • Routine studies to assess for meningitis
    • Opening pressure to assess for intracranial hypertension
    • Contraindicated when there is increased risk of herniation.
Treatment
  • Anticoagulation therapy
    • Whether or not hemorrhage is present, it is recommended to give low molecular weight heparin (LMWH) or intravenous heparin.
    • Minimum duration in all patients is 3 months but duration ultimately depends on clinical circumstance and range may be 3 months to lifelong, depending on the clinical scenario.
  • Treat any increased intracranial pressure
  • Antiepileptic therapy, if appropriate
MRV and Head CT Images of sigmoid sinus thrombosis from:
  • P Thomas, A Keightley, R Kamble, N Gunasekera, M R Johnson. Sigmoid sinus thrombosis presenting with posterior alexia in a patient with Behcet's disease and polycythaemia: a case report. Journal of Medical Case Reports 2008, 2:175 (23 May 2008)
REFERENCES
  • Chu K, Kang DW, Yoon BW, Roh JK. Diffusion-weighted magnetic resonance in cerebral venous thrombosis. Arch Neurol 2001; 58:1569.
  • Corvol JC, Oppenheim C, Manaï R, et al. Diffusion-weighted magnetic resonance imaging in a case of cerebral venous thrombosis. Stroke 1998; 29:2649.
  • Coutinho JM, Ferro JM, Canhão P, et al. Cerebral venous and sinus thrombosis in women. Stroke 2009; 40:2356.
  • Coutinho JM, Ferro JM, Zuurbier SM, et al. Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial. Int J Stroke 2013; 8:135.
  • Dentali F, Squizzato A, Gianni M, et al. Safety of thrombolysis in cerebral venous thrombosis. A systematic review of the literature. Thromb Haemost 2010; 104:1055.
  • Devasagayam S, Wyatt B, Leyden J, Kleinig T. Cerebral Venous Sinus Thrombosis Incidence Is Higher Than Previously Thought: A Retrospective Population-Based Study. Stroke 2016; 47:2180.
  • deVeber G, Andrew M, Adams C, et al. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345:417.
  • Duman T, Uluduz D, Midi I, et al. A Multicenter Study of 1144 Patients with Cerebral Venous Thrombosis: The VENOST Study. J Stroke Cerebrovasc Dis 2017; 26:1848.
  • Einhäupl K, Stam J, Bousser MG, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol 2010; 17:1229.
  • Ferro JM, Bousser MG, Canhão P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur J Neurol 2017; 24:1203.
  • Gotoh M, Ohmoto T, Kuyama H. Experimental study of venous circulatory disturbance by dural sinus occlusion. Acta Neurochir (Wien) 1993; 124:120.
  • Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45:2160.
  • Lauw MN, Barco S, Coutinho JM, Middeldorp S. Cerebral venous thrombosis and thrombophilia: a systematic review and meta-analysis. Semin Thromb Hemost 2013; 39:913.
  • Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:1158.
  • Siddiqui FM, Dandapat S, Banerjee C, et al. Mechanical thrombectomy in cerebral venous thrombosis: systematic review of 185 cases. Stroke 2015; 46:1263.
  • Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005; 352:1791.
  • Zuurbier SM, Hiltunen S, Lindgren E, et al. Cerebral Venous Thrombosis in Older Patients. Stroke 2018; 49:197.